Elicitation of T-cell-derived IFN-γ-dependent immunity by highly conserved Plasmodium ovale curtisi Duffy binding protein domain region II (PocDBP-RII)
Background Infections with Plasmodium ovale are widely distributed but rarely investigated, and the resulting burden of disease has been underestimated. Plasmodium ovale curtisi Duffy binding protein domain region II (PocDBP-RII) is an essential ligand for reticulocyte recognition and host cell invasion by P. ovale curtisi. However, the genomic variation, antigenicity and immunogenicity of PocDBP-RII remain major knowledge gaps. Methods A total of 93 P. ovale curtisi samples were collected from migrant workers who returned to China from 17 countries in Africa between 2012 and 2016. The genetic polymorphism, natural selection and copy number variation (CNV) were investigated by sequencing and real-time PCR. The antigenicity and immunogenicity of the recombinant PocDBP-RII (rPocDBP-RII) protein were further examined, and the humoral and cellular responses of immunized mice were assessed using protein microarrays and flow cytometry. Results Efficiently expressed and purified rPocDBP-RII (39 kDa) was successfully used as an antigen for immunization in mice. The haplotype diversity (Hd) of PocDBP-RII gene was 0.105, and the nucleotide diversity index (π) was 0.00011. No increased copy number was found among the collected isolates of P. ovale curtisi. Furthermore, rPocDBP-RII induced persistent antigen-specific antibody production with a serum IgG antibody titer of 1: 16,000. IFN-γ-producing T cells, rather than IL-10-producing cells, were activated in response to the stimulation of rPocDBP-RII. Compared to PBS-immunized mice (negative control), there was a higher percentage of $ CD4^{+} %$ CD44^{high} %$ CD62L^{−} $ T cells (effector memory T cells) and $ CD8^{+} %$ CD44^{high} %$ CD62L^{+} $ T cells (central memory T cells) in rPocDBP-RII‑immunized mice. Conclusions PocDBP-RII sequences were highly conserved in clinical isolates of P. ovale curtisi. rPocDBP-RII protein could mediate protective blood-stage immunity through IFN-γ-producing $ CD4^{+} $ and $ CD8^{+} $ T cells and memory T cells, in addition to inducing specific antibodies. Our results suggested that rPocDBP-RII protein has potential as a vaccine candidate to provide assessment and guidance for malaria control and elimination activities. Graphical Abstract.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Parasites & vectors - 16(2023), 1 vom: 08. Aug. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ren, Zhenyu [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| Anmerkungen: |
© The Author(s) 2023 |
|---|
| doi: |
10.1186/s13071-023-05897-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR05267746X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR05267746X | ||
| 003 | DE-627 | ||
| 005 | 20231121064859.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230809s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13071-023-05897-9 |2 doi | |
| 035 | |a (DE-627)SPR05267746X | ||
| 035 | |a (SPR)s13071-023-05897-9-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ren, Zhenyu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Elicitation of T-cell-derived IFN-γ-dependent immunity by highly conserved Plasmodium ovale curtisi Duffy binding protein domain region II (PocDBP-RII) |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2023 | ||
| 520 | |a Background Infections with Plasmodium ovale are widely distributed but rarely investigated, and the resulting burden of disease has been underestimated. Plasmodium ovale curtisi Duffy binding protein domain region II (PocDBP-RII) is an essential ligand for reticulocyte recognition and host cell invasion by P. ovale curtisi. However, the genomic variation, antigenicity and immunogenicity of PocDBP-RII remain major knowledge gaps. Methods A total of 93 P. ovale curtisi samples were collected from migrant workers who returned to China from 17 countries in Africa between 2012 and 2016. The genetic polymorphism, natural selection and copy number variation (CNV) were investigated by sequencing and real-time PCR. The antigenicity and immunogenicity of the recombinant PocDBP-RII (rPocDBP-RII) protein were further examined, and the humoral and cellular responses of immunized mice were assessed using protein microarrays and flow cytometry. Results Efficiently expressed and purified rPocDBP-RII (39 kDa) was successfully used as an antigen for immunization in mice. The haplotype diversity (Hd) of PocDBP-RII gene was 0.105, and the nucleotide diversity index (π) was 0.00011. No increased copy number was found among the collected isolates of P. ovale curtisi. Furthermore, rPocDBP-RII induced persistent antigen-specific antibody production with a serum IgG antibody titer of 1: 16,000. IFN-γ-producing T cells, rather than IL-10-producing cells, were activated in response to the stimulation of rPocDBP-RII. Compared to PBS-immunized mice (negative control), there was a higher percentage of $ CD4^{+} %$ CD44^{high} %$ CD62L^{−} $ T cells (effector memory T cells) and $ CD8^{+} %$ CD44^{high} %$ CD62L^{+} $ T cells (central memory T cells) in rPocDBP-RII‑immunized mice. Conclusions PocDBP-RII sequences were highly conserved in clinical isolates of P. ovale curtisi. rPocDBP-RII protein could mediate protective blood-stage immunity through IFN-γ-producing $ CD4^{+} $ and $ CD8^{+} $ T cells and memory T cells, in addition to inducing specific antibodies. Our results suggested that rPocDBP-RII protein has potential as a vaccine candidate to provide assessment and guidance for malaria control and elimination activities. Graphical Abstract | ||
| 650 | 4 | |a Genomic diversity |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Antigenicity |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Immunogenicity |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Shi, Qiyang |4 aut | |
| 700 | 1 | |a Xu, Simin |4 aut | |
| 700 | 1 | |a Xu, Jiahui |4 aut | |
| 700 | 1 | |a Yin, Yi |4 aut | |
| 700 | 1 | |a Lin, Zhijie |4 aut | |
| 700 | 1 | |a Xu, Sui |4 aut | |
| 700 | 1 | |a Ma, Xiaoqin |4 aut | |
| 700 | 1 | |a Liu, Yaobao |4 aut | |
| 700 | 1 | |a Zhu, Guoding |4 aut | |
| 700 | 1 | |a He, Xinlong |4 aut | |
| 700 | 1 | |a Lu, Jingyuan |4 aut | |
| 700 | 1 | |a Li, Yinyue |4 aut | |
| 700 | 1 | |a Zhang, Wenwen |4 aut | |
| 700 | 1 | |a Liu, Jiali |4 aut | |
| 700 | 1 | |a Yang, Yun |4 aut | |
| 700 | 1 | |a Han, Eun-Taek |4 aut | |
| 700 | 1 | |a Cao, Jun |4 aut | |
| 700 | 1 | |a Lu, Feng |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Parasites & vectors |d London : BioMed Central, 2008 |g 16(2023), 1 vom: 08. Aug. |w (DE-627)SPR030164583 |w (DE-600)2409480-8 |x 1756-3305 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2023 |g number:1 |g day:08 |g month:08 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s13071-023-05897-9 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2023 |e 1 |b 08 |c 08 | ||